Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 699

1.

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease.

Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A; PARS Investigators; Alzheimer's Disease Neuroimaging Initiative, Trojanowski JQ, Chen-Plotkin AS.

Ann Clin Transl Neurol. 2016 Mar 29;3(5):346-55. doi: 10.1002/acn3.299. eCollection 2016 May.

2.

The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.

Chow BS, Koulis C, Krishnaswamy P, Steckelings UM, Unger T, Cooper ME, Jandeleit-Dahm KA, Allen TJ.

Diabetologia. 2016 May 11. [Epub ahead of print]

PMID:
27168137
3.

Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.

Busch JI, Unger TL, Jain N, Tyler Skrinak R, Charan RA, Chen-Plotkin AS.

Hum Mol Genet. 2016 Apr 28. pii: ddw127. [Epub ahead of print]

PMID:
27126638
4.

[Molecular Pathological Aspects in Visceral Surgery].

Unger T, Sändig I, Wittekind C.

Zentralbl Chir. 2016 Apr;141(2):220-8. doi: 10.1055/s-0041-109548. Epub 2016 Apr 13. German.

PMID:
27074215
5.

Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice.

Schwengel K, Namsolleck P, Lucht K, Clausen BH, Lambertsen KL, Valero-Esquitino V, Thöne-Reineke C, Müller S, Widdop RE, Denton KM, Horiuchi M, Iwai M, Boato F, Dahlöf B, Hallberg A, Unger T, Steckelings UM.

J Mol Med (Berl). 2016 Mar 16. [Epub ahead of print]

PMID:
26983606
6.

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.

Abdul Razak AR, Mau-Soerensen M, Gabrail NY, Gerecitano JF, Shields AF, Unger TJ, Saint-Martin JR, Carlson R, Landesman Y, McCauley D, Rashal T, Lassen U, Kim R, Stayner LA, Mirza MR, Kauffman M, Shacham S, Mahipal A.

J Clin Oncol. 2016 Feb 29. pii: JCO653949. [Epub ahead of print]

PMID:
26926685
7.

Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders.

Paulis L, Foulquier S, Namsolleck P, Recarti C, Steckelings UM, Unger T.

Drugs. 2016 Jan;76(1):1-12. doi: 10.1007/s40265-015-0509-4.

8.

4C.02: PROLONGED ANGIOTENSIN II-INDUCED HYPERTENSION IMPAIRS SHORT-TERM MEMORY IN ADULT MICE.

Foulquier S, Namsolleck P, Recarti C, Van Hagen BT, Honig WM, Prickaerts J, Van Oostenbrugge RJ, Unger T.

J Hypertens. 2015 Jun;33 Suppl 1:e56. doi: 10.1097/01.hjh.0000467496.45095.81.

PMID:
26102858
9.

Relaxation dynamics and exciton energy transfer in the low-temperature phase of MEH-PPV.

Consani C, Koch F, Panzer F, Unger T, Köhler A, Brixner T.

J Chem Phys. 2015 Jun 7;142(21):212429. doi: 10.1063/1.4918645.

PMID:
26049449
10.

The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function.

Skorska A, von Haehling S, Ludwig M, Lux CA, Gaebel R, Kleiner G, Klopsch C, Dong J, Curato C, Altarche-Xifró W, Slavic S, Unger T, Steinhoff G, Li J, David R.

J Cell Mol Med. 2015 Aug;19(8):1975-85. doi: 10.1111/jcmm.12574. Epub 2015 May 20.

11.

A Recombinant Collagen-mRNA Platform for Controllable Protein Synthesis.

Sun L, Xiong Y, Bashan A, Zimmerman E, Shulman Daube S, Peleg Y, Albeck S, Unger T, Yonath H, Krupkin M, Matzov D, Yonath A.

Chembiochem. 2015 Jul 6;16(10):1415-9. doi: 10.1002/cbic.201500205. Epub 2015 May 26.

12.

Antiobesity Effect of a Small Molecule Repressor of RORγ.

Chang MR, He Y, Khan TM, Kuruvilla DS, Garcia-Ordonez R, Corzo CA, Unger TJ, White DW, Khan S, Lin L, Cameron MD, Kamenecka TM, Griffin PR.

Mol Pharmacol. 2015 Jul;88(1):48-56. doi: 10.1124/mol.114.097485. Epub 2015 Apr 22.

13.

Excess cardiovascular risk in diabetic women: a case for intensive treatment.

Recarti C, Sep SJ, Stehouwer CD, Unger T.

Curr Hypertens Rep. 2015 Jun;17(6):554. doi: 10.1007/s11906-015-0554-0. Review.

14.

[Prevention of bicycle accidents].

Zwipp H, Barthel P, Bönninger J, Bürkle H, Hagemeister C, Hannawald L, Huhn R, Kühn M, Liers H, Maier R, Otte D, Prokop G, Seeck A, Sturm J, Unger T.

Z Orthop Unfall. 2015 Apr;153(2):177-86. doi: 10.1055/s-0034-1396260. Epub 2015 Apr 14. German.

PMID:
25874397
15.

AT2R agonist, compound 21, is reno-protective against type 1 diabetic nephropathy.

Koulis C, Chow BS, McKelvey M, Steckelings UM, Unger T, Thallas-Bonke V, Thomas MC, Cooper ME, Jandeleit-Dahm KA, Allen TJ.

Hypertension. 2015 May;65(5):1073-81. doi: 10.1161/HYPERTENSIONAHA.115.05204. Epub 2015 Mar 16.

16.

Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells.

Menk M, Graw JA, von Haefen C, Sifringer M, Schwaiberger D, Unger T, Steckelings U, Spies CD.

Inflammation. 2015 Aug;38(4):1690-9. doi: 10.1007/s10753-015-0146-9.

PMID:
25758542
17.

Angiotensin type 2 receptors: blood pressure regulation and end organ damage.

Sumners C, de Kloet AD, Krause EG, Unger T, Steckelings UM.

Curr Opin Pharmacol. 2015 Apr;21:115-21. doi: 10.1016/j.coph.2015.01.004. Epub 2015 Feb 9. Review.

18.

From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients.

Eichler HG, Baird LG, Barker R, Bloechl-Daum B, Børlum-Kristensen F, Brown J, Chua R, Del Signore S, Dugan U, Ferguson J, Garner S, Goettsch W, Haigh J, Honig P, Hoos A, Huckle P, Kondo T, Le Cam Y, Leufkens H, Lim R, Longson C, Lumpkin M, Maraganore J, O'Rourke B, Oye K, Pezalla E, Pignatti F, Raine J, Rasi G, Salmonson T, Samaha D, Schneeweiss S, Siviero PD, Skinner M, Teagarden JR, Tominaga T, Trusheim MR, Tunis S, Unger TF, Vamvakas S, Hirsch G.

Clin Pharmacol Ther. 2015 Mar;97(3):234-46. doi: 10.1002/cpt.59. Epub 2015 Feb 4.

PMID:
25669457
19.

Dysfunctional cognitions of depressive inpatients and their relationship with treatment outcome.

Köhler S, Unger T, Hoffmann S, Mackert A, Ross B, Fydrich T.

Compr Psychiatry. 2015 Apr;58:50-6. doi: 10.1016/j.comppsych.2014.12.020. Epub 2015 Jan 13.

PMID:
25639696
20.

[Role of cardiovascular risk factors in the etiology of dementia].

Namsolleck P, Schmerler P, Unger T.

MMW Fortschr Med. 2014 Dec 15;156(21-22):83-4. Review. German. No abstract available.

PMID:
25608418
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk